{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Tonawanda",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "93154",
      "recalling_firm": "Pine Pharmaceuticals, LLC",
      "address_1": "355 Riverwalk Pkwy",
      "address_2": "N/A",
      "postal_code": "14150-5837",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0064-2024",
      "product_description": "Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.",
      "product_quantity": "860 syringes",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20231002",
      "center_classification_date": "20231019",
      "termination_date": "20240515",
      "report_date": "20231025",
      "code_info": "Lot #: 67808, Exp. Date 10/23/2023"
    }
  ]
}